Back
Schwab Emerging Markets Equity ETF Vs. Avidity Biosciences, Inc. Industry Stock Comparison
Sell
40
SCHE
Schwab Emerging Markets Equity ETF
Last Price:
$32.00
Seasonality Move:
1.32%
Buy
70
RNA
Avidity Biosciences, Inc.
Last Price:
$71.97
Seasonality Move:
40.87%
Sell
40
Schwab Emerging Markets Equity ETF (SCHE)
is a Sell
Is Schwab Emerging Markets Equity ETF a Buy, Sell or Hold?
-
The current Schwab Emerging Markets Equity ETF [SCHE] share price is $32.22. The Score for SCHE is 40, which is 20% below its historic median score of 50, and infers higher risk than normal.
-
SCHE is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
70
Avidity Biosciences, Inc. (RNA)
is a Buy
Is Avidity Biosciences, Inc. a Buy, Sell or Hold?
-
The current Avidity Biosciences, Inc. [RNA] share price is $71.86. The Score for RNA is 70, which is 40% above its historic median score of 50, and infers lower risk than normal.
-
RNA is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
SCHE Stock Price Chart
What is Schwab Emerging Markets Equity ETF's stock price today?
-
The Schwab Emerging Markets Equity ETF share price today is $32.22Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and SCHE is experiencing selling pressure, which indicates risk of future bearish movement.
RNA Stock Price Chart
What is Avidity Biosciences, Inc.'s stock price today?
-
The Avidity Biosciences, Inc. share price today is $71.86Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and RNA is experiencing buying pressure, which is a positive indicator for future bullish movement.
SCHE Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.21 | Sell |
| Relative Strength Index (14 RSI): | 31.59 | Sell |
| Chaikin Money Flow: | -2102213 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (32.85 - 33.83) | Sell |
| Bollinger Bands (100): | (31.61 - 33.83) | Sell |
RNA Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 1.83 | Buy |
| Relative Strength Index (14 RSI): | 75.83 | Buy |
| Chaikin Money Flow: | 1215204 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (70.7 - 71.66) | Buy |
| Bollinger Bands (100): | (41.02 - 66.72) | Buy |
SCHE Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 33.05 | Sell |
| 20-day SMA: | 33.17 | Sell |
| 50-day SMA: | 33.52 | Sell |
| 200-day SMA: | 30.64 | Buy |
| 8-day EMA: | 32.86 | Sell |
| 20-day EMA: | 33.17 | Sell |
| 50-day EMA: | 32.59 | Sell |
| 200-day EMA: | 20.48 | Buy |
RNA Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 71.55 | Buy |
| 20-day SMA: | 71.32 | Buy |
| 50-day SMA: | 64.13 | Buy |
| 200-day SMA: | 42.14 | Buy |
| 8-day EMA: | 71.59 | Buy |
| 20-day EMA: | 70.62 | Buy |
| 50-day EMA: | 64.65 | Buy |
| 200-day EMA: | 47.91 | Buy |
Schwab Emerging Markets Equity ETF Earnings Growth & SCHE Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Avidity Biosciences, Inc. Earnings Growth & RNA Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.26 per share, a decrease next quarter of $0.00 per share, a decrease this year of $1.63 per share, and a decrease next year of $0.41 per share.
Schwab Emerging Markets Equity ETF Technical Analysis
| Dec 2 | Dec 3 | Dec 4 | Dec 5 | Dec 8 | Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 15 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 02 | 03 | 04 | 05 | 08 | 09 | 10 | 11 | 12 | 15 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Avidity Biosciences, Inc. Technical Analysis
| Dec 2 | Dec 3 | Dec 4 | Dec 5 | Dec 8 | Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 15 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 02 | 03 | 04 | 05 | 08 | 09 | 10 | 11 | 12 | 15 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||